Elizabeth Bayliss to Dementia
This is a "connection" page, showing publications Elizabeth Bayliss has written about Dementia.
Connection Strength
3.447
-
Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trial. Patient Educ Couns. 2026 Jan; 142:109392.
Score: 0.766
-
Perspectives on Deprescribing Communication in Primary Care. J Gen Intern Med. 2021 04; 36(4):1122.
Score: 0.559
-
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study. J Gen Intern Med. 2020 12; 35(12):3556-3563.
Score: 0.534
-
Identifying Patient Portal Messages from Care Partners of People with Dementia. Clin Interv Aging. 2026; 21:620559.
Score: 0.204
-
Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias. BMC Geriatr. 2025 Dec 06; 26(1):39.
Score: 0.193
-
Systematic Identification of Caregivers of Patients Living With Dementia in the Electronic Health Record: Known Contacts and Natural Language Processing Cohort Study. J Med Internet Res. 2025 May 05; 27:e63654.
Score: 0.186
-
Improving How Caregivers of People Living With Dementia Are Identified in the Electronic Health Record: Qualitative Study and Exploratory Chart Review. JMIR Aging. 2024 Dec 13; 7:e59584.
Score: 0.181
-
Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia. JAMA Netw Open. 2023 10 02; 6(10):e2336728.
Score: 0.166
-
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023 01 08; 52(1).
Score: 0.158
-
Transforming Dementia Care Through Pragmatic Clinical Trials Embedded in Learning Healthcare Systems. J Am Geriatr Soc. 2020 07; 68 Suppl 2:S43-S48.
Score: 0.133
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020 Jun 18; 21(1):542.
Score: 0.132
-
Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019 03; 36(3):289-297.
Score: 0.121
-
Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden. Drugs Aging. 2018 03; 35(3):223-232.
Score: 0.113